Login / Signup

Deactivation of implantable cardioverter defibrillator in Japanese patients with end-stage heart failure.

Mayui NakazawaTsuyoshi SuzukiTsuyoshi ShigaAtsushi SuzukiNobuhisa Hagiwara
Published in: Journal of arrhythmia (2020)
Our study showed that only one-fourth of Japanese patients with end-stage HF underwent deactivation of ICD therapy. A relatively high frequency of shock therapy was observed in the last month before death.
Keyphrases
  • high frequency
  • heart failure
  • transcranial magnetic stimulation
  • left ventricular
  • atrial fibrillation
  • bone marrow
  • cell therapy